Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 4, 1996, Pages 451-455

  Cohen, Dani ^a   Orr, Naday ^a   Robin, Guy ^a   Slepon, Raphael ^a   Ashkenazi, Shai ^a,b   Ashkenazi, Isaac ^a   Shemer, Joshua ^a,b  

^a Israel Defense Force   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; LIPOPOLYSACCHARIDE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; PRIORITY JOURNAL; PROTEIN BINDING; SHIGELLOSIS; URINARY EXCRETION; VACCINATION;

EID: 0029861986     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.4.451-455.1996     Document Type: Article

References (13)

1. Alemohammad, M. M., T. J. Foley, and H. Cohen. 1993. Detection of immunoglobulin G antibodies to Helicobacter pylori in urine by enzyme immunoassay method. J. Clin. Microbiol. 31:2174-2177.
2. Carlson, B., Z. Shakila, L. Mellander, F. Jalil, and L. A. Hanson. 1985. Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination. J. Infect. Dis. 152:1238-1244.
3. Chu, C. Y., B. Liu, D. Watson, S. C. Szu, D. Bryla, J. Shiloach, R. Schneerson, and J. Robbins. 1992. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenleriae type 1 (Shisa's bacillus) bound to tetanus toxoid. Infect. Immun. 59:4450-4458.
4. Cohen, D., S. Ashkenazi, M. Green, M. Yavzori, N. Orr, R. Slepon, Y. Lerman, G. Robin, R. Ambar, C. Block, D. Taylor, L. Hale, J. Sadoff, and M. Wiener. 1994. Safety and immunogenicity of the oral E. coli k12-S. flexneri 2a vaccine (EcSf2a-2) among Israeli soldiers. Vaccine 12:1436-1442.
5. Cohen, D., M. Green, C. Block, G. Lowell, and I. Ofek. 1989. Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. J. Clin. Microbiol. 27: 162-167.
6. Cohen, D., M. S. Green, C. Block, R. Slepon, and I. Ofek. 1990. A prospective study on the association between serum antibodies to lipopolysaccharide and attack rate of shiuellosis. J. Clin. Microbiol. 29:386-389.
7. Cohen, D. I., M. Green, C. Block, T. M. Rouach, and I. Ofek. 1988. Serum anti-lipopolysaccharide (LPS) antibodies and natural immunity to shigellosis in an Israeli military population. J. Infect. Dis. 157:1068-1071.
8. Fliedner, M., O. Mehls, E.-W. Raterberg, and E. Ritz. 1986. Urinary sIgA in children with urinary tract infection. J. Pediatr. 109:416-421.
9. Ganguly, R., L. W. Clem, Z. Bencic, R. Sinha, R. Sakazaki, and R. H. Waldman. 1975. Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines. Bull. W. H. O. 52:323-330.
10. Kauppi, M., J. Eskola, and H. Kayhty. 1995. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influcnzae type b conjugate vaccine. Pediatr. Infect. Dis. J. 16:285-296.
11. Kruze, D., K. Holzbecher, M. Andrial, and W. Bossarrt. 1989. Urinary antibody response after immunisation with a vaccine against urinary tract infection. Urol. Res. 17:361-366.
12. Levenson, V. I., E. V. Chernokhvostova, M. M. Lyubinskaja, S. A. Salamatova, E. K. Dzhikidze, and Z. K. Stasilevitch. 1988. Parenteral immunization with Shigella ribosomal vaccine elicits local IgA response and primes for mucosal memory. Int. Arch. Allergy Appl. Immunol. 87:25-31.
13. Levine, M. M., H. L. DuPont, E. J. Gangarosa, R. B. Hornick, M. J. Snyder, J. P. Libonati, K. Glaser, and S. B. Formal. 1972. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated Shigella vaccines. Am. J. Epidemiol. 966:40-49.